Orchestra BioMed Holdings, Inc. (OBIO) stock
Close on Nov 13, 2026Market cap $435.76MP/E –Yield –
Orchestra BioMed statistics
72 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 10.70
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 51.7%
- 3.32%
- Shares Change (QoQ)
- 2.24%
- 0.20%
- Float
- 26M
- 37M
- Shares Held by Insiders
- 56.6%
- 10.5%
- Shares Held by Institutions
- 46.1%
- 60.5%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- 7.03%
- -2.57%
- Short % of Float
- 10.5%
- 5.11%
- Short % of Shares Outstanding
- 4.55%
- 3.98%
- Days to Cover
- 6.99
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $7.37
- –
- 52-Week Low
- $3.46
- –
- 20-Day Moving Average
- $5.85
- –
- 50-Day Moving Average
- $5.86
- –
- 200-Day Moving Average
- $4.63
- –
- Average True Range (14)
- $0.48
- –
- Price Change (1 Week)
- 27.6%
- 0.99%
- Price Change (1 Month)
- 26.3%
- -3.52%
- Price Change (3 Months)
- 53.6%
- -7.86%
- Price Change (6 Months)
- 94.9%
- -1.12%
- Price Change (YTD)
- 74.7%
- -2.92%
- Price Change (1 Year)
- 64.0%
- -1.37%
- Price Change (3 Years)
- 6.15%
- 3.24%
- Price Change (5 Years)
- -26.5%
- -50.4%
- Average Volume (10 Days)
- 684,858
- –
- Average Volume (20 Days)
- 538,084
- –
- Average Volume (90 Days)
- 350,917
- –
- Relative Volume
- 4.67
- 0.76
- Relative Strength Index (14)
- 72.1
- 46.7
- Volatility (1 Year)
- 65.6%
- 64.2%
- Beta (5 Years)
- 0.84
- 1.04
MarginsIndustry
- EBITDA Margin
- -194.2%
- -2.52%
- FCF Margin
- -205.7%
- 0.65%
Returns on capitalIndustry
- Return on Assets (ROA)
- -53.6%
- -12.3%
- Return on Capital Employed (ROCE)
- -65.2%
- -8.13%
Financial positionIndustry
- Current Ratio
- 7.25
- 2.49
- Quick Ratio
- 7.17
- 1.53
GrowthIndustry
- Revenue Growth (YoY)
- 1007.4%
- 9.42%
- Revenue Growth (3Y CAGR)
- 111.6%
- 7.08%
EfficiencyIndustry
- Asset Turnover
- 0.29
- 0.59
- Inventory Turnover
- 0.46
- 2.20
- Revenue Per Employee
- $362.86K
- $331.99K
- Profits Per Employee
- -$662.22K
- -$46.47K
- Employee Count
- 86
- 193
- WACC
- 9.30%
- 9.91%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $101.91M
- $3.95M
- Net Cash Per Share
- $1.70
- $0.26
- Working Capital
- $88.94M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$869.00K
- -$3.94M
- FCF Per Share
- -$1.07
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -13.1%
- -4.76%
- FCF Yield
- -14.7%
- 0.28%
Scores and fair valueIndustry
- Altman Z-Score
- -3.18
- 2.47
- Piotroski F-Score
- 6
- 5
- Beneish M-Score
- 7.03
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | OBIO | S&P 500 | Difference | OBIO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +26.7% | -3.0% | +29.8 pts | ||
| 3 months | +62.9% | -2.8% | +65.7 pts | ||
| Year to date | +74.7% | +11.5% | +63.2 pts | ||
| 1 year | +73.4% | +13.5% | +60.0 pts | ||
| 3 years | +20.0% | +77.7% | −57.7 pts | +6.3% | +21.1% |
| 5 years | -26.5% | +72.6% | −99.1 pts | -6.0% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M OBIO shares were sold short on Oct 30, 2026, up 7.0% from the previous report, or 10.48% of the shares available to trade. At recent volumes it would take 7.0 days to buy them back. Over the last 20 sessions, 50.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 2,732,484 | +7.0% | 390,641 | 7.0 |
| Oct 15, 2026 | 2,552,988 | +0.2% | 263,110 | 9.7 |
| Sep 30, 2026 | 2,547,249 | +7.4% | 364,835 | 7.0 |
| Sep 15, 2026 | 2,372,557 | -3.6% | 360,954 | 6.6 |
| Aug 31, 2026 | 2,460,669 | +3.2% | 422,681 | 5.8 |
| Aug 14, 2026 | 2,383,854 | -1.7% | 181,707 | 13.1 |
| Jul 31, 2026 | 2,425,602 | -6.3% | 181,418 | 13.4 |
| Jul 15, 2026 | 2,588,912 | +16.4% | 238,346 | 10.9 |
| Jun 30, 2026 | 2,223,290 | +79.5% | 821,124 | 2.7 |
| Jun 15, 2026 | 1,238,648 | +30.6% | 220,226 | 5.6 |
| May 29, 2026 | 948,245 | +12.6% | 251,730 | 3.8 |
| May 15, 2026 | 842,294 | -13.4% | 262,079 | 3.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?